Trevi Therapeutics (TRVI)
Nasdaq • TRVI • US89532M1018
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 22, 2026, ORTEX estimated 12.9% of free float sold short, 5.3 days to cover, cost to borrow 0.44%. Sign up for live short interest data.
Market Cap
1.83b USD | # 4052 in US
Volume
1.93m shares | 29.38m USD
Shares Outstanding
142.48m
Free Float Shares
83.05% | 118.32m
